Skip to main content

Aggregator

Ramelteon suppresses astrocytic senescence via MT1-cAMP axis to protect dopaminergic neurons

1 week 4 days ago
INTRODUCTION: Astrocytic senescence is increasingly recognized as a critical contributor to the pathogenesis of Parkinson's disease (PD). Ramelteon, a clinically approved MT1/MT2 melatonin receptor agonist, has demonstrated neuroprotective effects in various neurological disorders. However, whether Ramelteon can inhibit astrocytic senescence and the underlying mechanisms remain unknown.
Chao Gu

White matter hyperintensities and amyloid pathology in cognitively unimpaired aging: topographical, microstructural, and network-level evidence

1 week 4 days ago
The frequent coexistence of white matter hyperintensities (WMHs) and β-amyloid (Aβ) pathology in cognitively unimpaired older adults complicates interpretation of vascular and neurodegenerative imaging findings. This narrative review synthesizes topographical, microstructural, and network-level evidence in cognitively unimpaired aging, distinguishing biomarker-characterized samples from supportive mixed or symptomatic cohorts. WMHs have heterogeneous etiologies. Posterior and some...
Sana Mohammadi

FGF13 Alleviates the Aging Process in Mice by Regulating Astrocyte Function in the Medial Prefrontal Cortex via Phafin2 Signaling Pathway

1 week 4 days ago
Aging is an intrinsic biological process; specifically, brain aging leads to cognitive decline, memory loss, and numerous neurodegenerative diseases. Fibroblast growth factor 13 (FGF13) is expressed in the central nervous system (CNS) and plays a critical role in several neuropathological conditions; however, the specific role of FGF13 in brain aging remains unclear. In this study, screening of public gene expression databases revealed that FGF13 is significantly downregulated in the brain...
Rui Zheng